Boston Scientific Corp (BSX)
91.50
+1.33
(+1.48%)
USD |
NYSE |
Nov 21, 16:00
91.40
-0.10
(-0.11%)
Pre-Market: 07:36
Boston Scientific Revenue (TTM): 15.91B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 15.91B |
| June 30, 2024 | 15.23B |
| March 31, 2024 | 14.71B |
| December 31, 2023 | 14.24B |
| September 30, 2023 | 13.76B |
| June 30, 2023 | 13.40B |
| March 31, 2023 | 13.04B |
| December 31, 2022 | 12.68B |
| September 30, 2022 | 12.57B |
| June 30, 2022 | 12.33B |
| March 31, 2022 | 12.16B |
| December 31, 2021 | 11.89B |
| September 30, 2021 | 11.47B |
| June 30, 2021 | 11.20B |
| March 31, 2021 | 10.12B |
| December 31, 2020 | 9.914B |
| September 30, 2020 | 10.11B |
| June 30, 2020 | 10.16B |
| March 31, 2020 | 10.78B |
| December 31, 2019 | 10.74B |
| September 30, 2019 | 10.39B |
| June 30, 2019 | 10.08B |
| March 31, 2019 | 9.937B |
| December 31, 2018 | 9.823B |
| September 30, 2018 | 9.67B |
| Date | Value |
|---|---|
| June 30, 2018 | 9.499B |
| March 31, 2018 | 9.266B |
| December 31, 2017 | 9.047B |
| September 30, 2017 | 8.83B |
| June 30, 2017 | 8.713B |
| March 31, 2017 | 8.582B |
| December 31, 2016 | 8.386B |
| September 30, 2016 | 8.173B |
| June 30, 2016 | 7.956B |
| March 31, 2016 | 7.673B |
| December 31, 2015 | 7.477B |
| September 30, 2015 | 7.386B |
| June 30, 2015 | 7.344B |
| March 31, 2015 | 7.374B |
| December 31, 2014 | 7.38B |
| September 30, 2014 | 7.331B |
| June 30, 2014 | 7.22B |
| March 31, 2014 | 7.156B |
| December 31, 2013 | 7.143B |
| September 30, 2013 | 7.126B |
| June 30, 2013 | 7.126B |
| March 31, 2013 | 7.145B |
| December 31, 2012 | 7.25B |
| September 30, 2012 | 7.277B |
| June 30, 2012 | 7.416B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
9.914B
Minimum
Dec 2020
15.91B
Maximum
Sep 2024
12.32B
Average
12.25B
Median
Revenue (TTM) Benchmarks
| Baxter International Inc | 17.28B |
| Haemonetics Corp | 1.361B |
| ResMed Inc | 4.807B |
| Globus Medical Inc | 2.479B |
| Abbott Laboratories | 41.22B |